Arnatar Therapeutics
Pre-clinicalArnatar is reimagining RNA medicines to precisely silence disease drivers or restore what’s missing. Through our dual-modality DARGER™ platform, we develop best-in-class siRNA and first-in-class upregulating ASOs for cardiometabolic, liver, CNS, and kidney diseases.
Founded
2021
Focus
OncologyImmunology
About
Arnatar is reimagining RNA medicines to precisely silence disease drivers or restore what’s missing. Through our dual-modality DARGER™ platform, we develop best-in-class siRNA and first-in-class upregulating ASOs for cardiometabolic, liver, CNS, and kidney diseases.
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile